SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

Shree Ganesh Biotech (India) L

BSE: 539470 09 Sep 2025
Healthcare
₹ 0.78
Shree Ganesh Biotech (India) Limited specializes in Biotechnology within the Healthcare sector.

Shree Ganesh Biotech (India) L - Share Price & Details

Market Cap
₹31.1
High /Low
1.25 / 0.74
Stock P/E
66.2
Book Value
₹1.59
Dividend Yield
0.0
ROCE
0.62
ROE
₹0.44
Face Value
1.0
PEG Ratio
-1.27
EVEBITDA
₹66.1
Debt
0.00
CMP / FCF
8.89
Debt to equity
₹0.0
NP Ann
0.28
High price all time
24.7
Piotroski score
₹4.0
Graham Number
0.65
No. Eq. Shares
39.9
Net CF
₹-0.41
Net profit
0.47
Price to book value
0.49
Interest Coverage
₹NA
Low price all time
0.7
Industry PE
64.9
Reserves
₹23.4
Free Cash Flow
₹-10.2

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
FABINO ENTERPRISES LIMITEDNANANANA5.4691.0
Triochem Products Ltd.,NANANANA0
Shree Ganesh Biotech (India) LNANANANA31.166.2
KK Shah Hospitals LimitedNANANANA30.3
GUJARAT INJECT (KERALA) LTD.NANANANA30.231.5

Peer Comparison Chart


About Shree Ganesh Biotech (India) L

Shree Ganesh Biotech (India) Limited, with Security Code 539470, is a leading player in the Biotechnology industry, categorized under the Healthcare sector, offering Equity instruments.


Latest News

Shree Ganesh Biotech Hits New Low Amid Broader Market Caution and Sector Trends

(11 Aug 2025)
Shree Ganesh Biotech India, a microcap in the Pharmaceuticals & Biotechnology sector, reached a new 52-week low today, reflecting a year-to-date decline.
Read more →

Shree Ganesh Biotech Faces Financial Struggles Amid Significant Stock Decline

(30 Jul 2025)
Shree Ganesh Biotech India, a microcap in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low, reflecting a...
Read more →

ShreeGanesh Bio Standalone June 2025 Net Sales at Rs 1.38 crore, down 61.09% Y-o-Y

(30 Jul 2025)
Net Sales at Rs 1.38 crore in June 2025 down 61.09% from Rs. 3.56 crore in June 2024. Story continues below Advertisement.
Read more →

Shree Ganesh Biotech Hits 52-Week Low Amid Broader Market Decline and Financial Struggles

(26 Jul 2025)
Shree Ganesh Biotech India, a microcap in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low, significantly underperforming the...
Read more →

Q1 Results Today: Bajaj Finserv, Cipla, SAIL, Bank of Baroda Among 80+ Companies to Announce Earnings

(26 Jul 2025)
A large and diverse set of Indian companies across multiple sectors are set to announce their Q1 FY26 earnings today, July 25, 2025.
Read more →

Shree Ganesh Biotech India standalone net profit rises 37.50% in the June 2025 quarter

(23 Jul 2025)
Net profit of Shree Ganesh Biotech India rose 37.50% to Rs 0.33 crore in the quarter ended June 2025 as against Rs 0.24 crore during the...
Read more →

Company Updates